Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVB-2640 in KRAS Mutant Non-small Cell Lung Carcinomas
NCT03808558Phase 2Active, not recruiting
- Sponsor
- David E Gerber
- Start
- Sep 2019
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of denifanstat in non-small cell lung cancer (NSCLC), sponsored by David E Gerber. Started Sep 2019; status: active, not recruiting.
02
Drugs
denifanstat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03808558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03808558.